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Background. Abnormalities in incentive decision making, typically assessed using the Iowa Gambling Task (IGT),
have been reported in both schizophrenia (SZ) and bipolar disorder (BD). We applied the Expectancy–Valence (E–V)
model to determine whether motivational, cognitive and response selection component processes of IGT performance
are diﬀerentially aﬀected in SZ and BD.
Method. Performance on the IGT was assessed in 280 individuals comprising 70 remitted patients with SZ,
70 remitted patients with BD and 140 age-, sex- and IQ-matched healthy individuals. Based on the E–V model, we
extracted three parameters, ‘ attention to gains or loses ’, ‘ expectancy learning ’ and ‘ response consistency ’, that
respectively reﬂect motivational, cognitive and response selection inﬂuences on IGT performance.
Results. Both patient groups underperformed in the IGT compared to healthy individuals. However, the source
of these deﬁcits was diagnosis speciﬁc. Associative learning underlying the representation of expectancies was
disrupted in SZ whereas BD was associated with increased incentive salience of gains. These ﬁndings were not
attributable to non-speciﬁc eﬀects of sex, IQ, psychopathology or medication.
Conclusions. Our results point to dissociable processes underlying abnormal incentive decision making in BD and
SZ that could potentially be mapped to diﬀerent neural circuits.
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Introduction
Incentive decision making is a pervasive and funda-
mental mental operation. Incentive decision making
occurs whenever a choice needs to be made between
competing alternatives based on the value ascribed
to this choice. Current theoretical models (Busemeyer
& Johnson, 2004; Berridge & Kringelbach, 2008) pro-
pose that incentive decision making encompasses
the following processes : (a) forming associations
between stimuli and their outcomes, (b) assigning
them a value, (c) extracting general principles from
contingencies to predict the outcome, (d) implement-
ing perceptual and response biases based on the
assigned value, and (e) evaluating outcome and ad-
justing performance.
The Iowa Gambling Task (IGT; Bechara et al. 1994),
a simulated gambling task, is a prototypical tool for
investigating the processes underpinning incentive
decision making. The IGT requires participants to
select cards arranged in four decks. Each card has a
monetary value that is revealed only after it has been
selected, and can either be a gain or a loss. The par-
ticipants’ aim is to optimize their net gains across
trials. Two of the decks have high rewards (gains) but
also higher punishments (losses), resulting in monet-
ary loss over time and they are therefore disadvan-
tageous. The other two decks have lower rewards but
also lower punishments, making them advantageous
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in the long term. Participants are not told about the
distribution of gains and losses associated with each
deck but must deduce this from experience during the
task. Over several trials, healthy individuals learn to
favour the advantageous cards.
It has long been recognized that poor performance
in the IGT may arise from markedly diﬀerent deﬁcits
in the processes that underpin incentive decision
making. Busemeyer & Stout (2002) proposed a math-
ematical model based on the concepts of expectancy
(anticipated outcome based on previous experience)
and valence (value ascribed to the outcome) to analyse
trial-by-trial behaviour during the IGT. This model
(detailed in the online supplementary material) yields
three parameters that map on the basic component
processes of incentive decision making: (a) attention to
gains or losses (motivational parameter), representing
the relative inﬂuence of wins and losses on the pattern
of responding; (b) expectancy learning (learning
parameter), a measure of the ability to use associative
learning over several trials to anticipate the outcome of
future trials ; and (c) response consistency, a measure
of consistency of the pattern of responding. Based on
this model, greater attention to gains would increase
the tendency to choose from high gain disadvan-
tageous decks. Individuals with poor expectancy
learning would be more inﬂuenced by the most recent
outcome of a trial and less by associative memories of
more distant outcomes. Inconsistent or erratic choices
suggest diﬃculties in applying learned expectancies
about outcome during card selection.
The focus of the present study was to examine
whether these component processes of decision mak-
ing are diﬀerentially aﬀected in schizophrenia (SZ)
and bipolar disorder (BD).
There is renewed interest in incentive- or reward-
based processing in the major psychoses that reﬂects,
in part, recent insights into the eﬀect of dopamine on
the cognitive and motivational aspects of incentive
decision making (Bellani et al. 2009 ; Ziauddeen &
Murray, 2010). There is a great deal of evidence that
dopaminergic input may be segregated into two
complementary and interactive networks ; striatal-
dorsal prefrontal cortical circuits are implicated in the
associative learning that underlies representation of
expectancies whereas ventral prefrontal networks are
involved in representing the motivational value of re-
ward (Schultz 1998, 2002 ; Ursu & Carter, 2005 ; Frank
& Claus, 2006). In SZ there is evidence of disruption in
associative learning (Barch, 2005) whereas both dis-
orders may have abnormalities in the representation of
motivational value (Gold et al. 2008; Chandler et al.
2009 ; Bermpohl et al. 2010). Examination of the cogni-
tive and motivational processes during the IGT in SZ
and BD would therefore contribute to the ongoing
debate about the shared and unique features of the
major psychoses (Lawrie et al. 2010).
Our study builds upon evidence that overall per-
formance in the IGT is abnormal in both disorders
(Clark et al. 2001 ; Beninger et al. 2003 ; Ritter et al. 2004;
Shurman et al. 2005 ; Christodoulou et al. 2006 ; Sevy
et al. 2007 ; Bellani et al. 2009; Premkumar et al. 2008 ;
Lee et al. 2009 ; Adida et al. 2011), although there have
been negative studies (e.g. Cavallaro et al. 2003 ;
Martino et al. 2011). Three studies to date, one in BD
(Yechiam et al. 2008) and two in SZ (Sevy et al. 2007 ;
Premkumar et al. 2008), have examined IGT perform-
ance in terms of Expectancy–Valence (E–V) par-
ameters. Two of these studies were inconclusive (Sevy
et al. 2007; Yechiam et al. 2008) whereas Premkumar
et al. (2008) found that patients with SZ showed re-
duced expectancy learning but were comparable to
controls in terms of attention to gains or losses.
Thus our tentative predictions were that, during the
IGT, SZ would be associated with reduced expectancy
learning, the cognitive component of the task, whereas
BD would be associated with increased attention
to gains or losses, the motivational component of
the task. To test these hypotheses we compared
70 patients with SZ to 70 patients with BD and 140
healthy individuals. We enrolled patients who were in
remission to reduce the potential confounding eﬀects
of symptoms (Clark et al. 2001 ; Sevy et al. 2007 ;
Yechiam et al. 2008 ; Adida et al. 2011). Patients were
matched to healthy individuals on age, sex and gen-
eral intellectual ability (IQ) to minimize the inﬂuence
of demographic and non-speciﬁc cognitive factors on
task performance (Toplak et al. 2010).
Method
Sample
Participants were recruited at two sites at the
University of Verona (UoV), Italy and at the Institute
of Psychiatry (IoP), King’s College London, UK, as
part of an ongoing collaboration (Tomelleri et al. 2009).
This enabled us to enrol suﬃcient numbers of remitted
patients. Based on our previous work (Christodoulou
et al. 2006 ; Premkumar et al. 2008), we estimated a
sample size of 70 patients in each diagnostic group for
a power of 0.80 and an a level of<0.05. At both sites,
patients were recruited by clinicians’ referrals if they
(a) were aged 18–65 years and (b) fulﬁlled DSM-IV-R
(APA, 1994) criteria for SZ or BD type I. Age-, sex- and
IQ-matched healthy individuals without a personal
history of any Axis I disorder or a family history of SZ
or BD (up to second-degree relatives) were recruited
from the respective local communities through ad-
vertisement. Exclusion criteria for the entire sample
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(patients and controls) included (a) head trauma re-
sulting in loss of consciousness, (b) personal history of
neurological or medical disorders, (c) family history of
hereditary neurological disorders, and (d) fulﬁlling
DSM-IV criteria for lifetime drug or alcohol depen-
dence and drug or alcohol abuse in the preceding
6 months. The study was approved by the joint
South London and Maudsley and IoP National
Health Service (NHS) Research Ethics Committee and
the Biomedical Ethics Committee of the Azienda
Ospedaliera of Verona. Written informed consent was
obtained from all participants.
Clinical assessment
At both sites clinical assessment of all participants was
conducted by trained psychiatrists using structured
diagnostic interviews. Diagnostic reliability (0.958)
between sites was conﬁrmed by bilingual psychiatrists
on a random selection of 14 patients (10% of the
sample). At the UoV, diagnoses were obtained using
the Italian version of the Item Group Checklist of the
Schedule for Clinical Assessment in Neuropsychiatry
(IGC-SCAN) because the group had extensive experi-
ence with this instrument and had contributed to its
standardization in Italy (Peruzzo et al. 2011). At the
IoP, diagnostic assessments were performed using the
SCID, patient and non-patient editions (SCID-I/P and
SCID-I/NP; First et al. 2002a, b). At both sites, psy-
chopathology was assessed using the 24-item Brief
Psychiatric Rating Scale (BPRS; Luckoﬀ et al. 1986)
in addition to more disorder-speciﬁc instruments : the
Hamilton Depression Rating Scale (HAMD; Hamilton,
1960) and the Young Mania Rating Scale (YMRS;
Young et al. 1978) for patients with BD and the Positive
and Negative Syndrome Scale (PANSS; Kay et al. 1987)
for patients with SZ. The BPRS was chosen as the pri-
marymeasure of psychopathology as it is applicable to
both patient groups and to non-psychiatric popu-
lations.
Information about current type and dose of medi-
cation was collected for all patients. The comparable
daily dose in chlorpromazine equivalents (CPZE) was
calculated for current antipsychotic use when relevant
(Bezchlibnyk-Butler & Jeﬀries 2000).
Cognitive assessment
Both sites used the same cognitive battery. Evaluations
were conducted by trained psychologists when
patients were in remission, which was deﬁned as
scoring f3 on the positive and negative BPRS items
on the day of the assessment (Nuechterlein et al. 2006).
In the BPRS, symptoms are rated from 1 (absent) to
7 (extremely severe). Item scores of 2 and 3 correspond
to very mild and mild symptoms.
An estimate of IQ was obtained using the language-
appropriate version of the Wechsler Adult Intelligence
Scale – Revised (WAIS-R; Wechsler, 1981; Orsini &
Laicardi, 1997). Assessment of incentive decision
making was based on the IGT and the Wisconsin Card
Sorting test (WCST; Nelson, 1976) was used to exam-
ine non-incentive executive function. The computer-
ized versions of the WCST and the IGT used here
were previously validated in studies of BD and SZ
(Donaldson et al. 2003 ; Frangou et al. 2005, 2006 ;
Christodoulou et al. 2006 ; Premkumar et al. 2008 ;
Ruberto et al. 2011). These tests were administered at
both sites in a ﬁxed order as reported here.
The performance of patients with SZ or BD on the
WCST has been examined extensively (Stefanopoulou
et al. 2009). The sole purpose of including the WCST
here is to serve as a non-incentive decision-making
task to aid in interpreting potential group diﬀerences
between motivational and associative learning di-
mensions of decision making. The WCST version used
consists of four stimulus cards [displaying diﬀerent
shapes (crosses, circles, triangles or stars) in diﬀerent
colours and diﬀerent numbers] and a single deck of 36
response cards with displays similar to the stimulus
cards. Participants were asked to match each response
card to one of the stimulus cards on the basis of a
series of categories (shape, colour or number) about
which they had no a priori knowledge. After each
selection, feedback was given and a diﬀerent response
card was displayed. The card-sorting category
changed after a number of correct responses. The
WCST requires participants to use outcome–feedback
to form abstract notions of ‘categories ’ for matching
stimuli. In this respect the processes of decision mak-
ing during the WCST closely approximate those in-
volved in the IGT except that the incentive value of the
WCST stimuli is very low. At the initial stages of both
tasks, participants chose cards randomly as they are
not given any information about stimulus–outcome
associations. Following feedback, participants gradu-
ally learn the stimulus–outcome associations and
adapt their responses accordingly. We therefore ex-
pected that categories achieved in the WCST would
correlate with expectancy learning in the IGT.
During the IGT participants were instructed to
choose a card from four decks (A, B, C, D). Each
deck had diﬀerent reward/punishment proﬁles about
which participants had no a priori knowledge. At the
beginning of the task, participants received a loan of
pretend money and were asked to optimize their gains
through their card choices. Each deck had 60 cards and
participants were given 100 trials. Decks A and B
were ‘disadvantageous’ as deck A had frequent,
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small-magnitude punishments and deck B had in-
frequent, but higher, punishments. By contrast, decks
C and D were ‘advantageous’ as deck C had frequent,
small rewards, and deck D had infrequent, higher re-
wards. Dividing card selections into ﬁve blocks of 20
allowed us to monitor progress over the course of the
task. Performance was evaluated using (a) the net
score, calculated for each block by subtracting the total
number of disadvantageous decks chosen from the
total number of advantageous decks [(C+D) –
(A+B)], (b) the global net score, which is the sum of
the net scores per block, and (c) parameters based on
the E–V model. Trial number, card selected in each
trial and the associated monetary loss or gain were
imported into a text ﬁle and analysed in Matlab
6.1 (MathWorks, USA), as described previously
(Premkumar et al. 2008) and detailed in the online
supplementary material, to calculate the model’s three
components, as follows. (a) Attention to gains or losses
(motivational parameter) : this parameter ranges from
0 to 1. Smaller values reﬂect attention to losses and
higher values denote attention to gains, which may
lead to a preference for the high-risk disadvantageous
decks. (b) Expectancy learning (learning parameter) :
the expectancy of each deck is adjusted based on the
outcome of previous experience of choosing this deck
and on the payoﬀ of the most recent choice. This par-
ameter ranges from 0 to 1. Small values indicate small
adjustments and larger values reﬂect greater adjust-
ments inﬂuenced by the outcome of the most recent
choice rather than past experience. (c) Response con-
sistency (response–sensitivity parameter) : this par-
ameter ranges from x5 (random choices) to +5
(consistent choices that are highly dependent on
expectancy).
Statistical analysis
We used analyses of variance (ANOVAs) and x2 tests
to examine group diﬀerences in age, sex, IQ and BPRS
total score. Performance in the IGT was ﬁrst examined
using a block-by-group (SZ patients, BD patients,
healthy individuals) mixed factorial analysis of co-
variance (ANCOVA) of the net score. Additionally,
separate ANCOVAs were performed to test for group
diﬀerences in each of the E–V parameters and in the
WCST outcome variables. In all analyses, BPRS and IQ
were retained as covariates to remove any variance
attributable to non-speciﬁc eﬀects of symptoms or IQ.
For the IGT analyses, sex was included as an ad-
ditional factor based on previous reports of sex
diﬀerences on this task (Reavis & Overman, 2001).
Correlations between performance variables from
the IGT and WCST were examined in addition to
correlations between performance variables and
antipsychotic medication dose at the time of testing,
age of onset and duration of illness. The results of
these analyses were considered signiﬁcant at p<0.005
following Bonferroni correction for multiple testing.
We also report eﬀect sizes of selected group diﬀer-
ences based on Cohen’s d (Cohen, 1998).
The eﬀect of site was investigated in two ways. First,
within each diagnostic group we compared the UoV
to the IoP sample on each performance variable. All
comparisons were non-signiﬁcant (p<0.7) and of
negligible eﬀect size (d<0.06). Second, we repeated all
analyses using site as an additional independent factor
but no main or interactive eﬀects of site were detected.
For simplicity we report the results without including
site as a factor as it had no eﬀect on the ﬁndings. In
addition to the primary analyses, we examined the
inﬂuence of diﬀerences in rates of psychosis between
the two diagnostic groups and in the prevalence of
smoking.
Results
Sample
Details of the demographic and clinical characteristics
of the sample are presented in Table 1. Twenty-nine
patients with SZ, 34 patients with BD and 61 healthy
individuals were recruited at the UoV and the re-
mainder at the IoP. There were no group diﬀerences in
age (F2,237=2.10, p=0.13), sex distribution (x2=2.39,
p=0.30) or IQ (F2,237=1.17, p=0.18). The mean total
scores (S.D.) for the HAMD and YMRS of the patients
with BD were 1.54 (1.73) and 0.81 (0.87) respectively.
The PANSS mean total score (S.D.) of patients with
SZ was 42 (5.04). The scores on these scales were
highly correlated with the total BPRS score (r>0.7),
which was the primary measure of psychopathology.
Despite the low levels of psychopathology, there was
a signiﬁcant group diﬀerence in BPRS total score
(F2,237=51.42, p<0.0001) ; patients with BD were less
symptomatic than patients with SZ (p=0.04) but both
patient groups had higher scores than healthy in-
dividuals (p<0.0001). The two patient groups did not
diﬀer in age of onset (p=0.38) or duration of illness
(p=0.76). All patients were medicated with a var-
iety of psychotropics. The majority received second-
generation antipsychotics (SGAs; olanzapine=51,
risperidone=29, quetiapine=23) ; those on ﬁrst-
generation antipsychotics (FGAs) received injectable
formulations. The two patient groups did not diﬀer in
mean antipsychotic dose (p=0.7) [mean CPZE (S.D.) :
patients with SZ=497.9 (384.4) ; patients with BD=
495.4 (299.1)]. Patients prescribed antidepressants
were on a variety of selective serotonin reuptake
inhibitors (SSRIs ; citalopram=7, sertraline=4,
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ﬂuoxetine=2). Three patients with SZ were prescribed
sodium valproate for arousal according to their notes.
The mood stabilizers prescribed in the BD group
were lithium (n=31), sodium valproate (n=23),
carbamazepine (n=1) and lamotrigine (n=4). None
of the patients were on regular benzodiazepines or
anticholinergics or had taken any in the preceding
2 weeks. There was a signiﬁcant diﬀerence in the pro-
portion of participants who reported regular cigarette
smoking (healthy individuals : 7%; SZ patients : 89%;
BD patients : 65%).
WCST
Details of participants’ performance in the WCST are
shown in Table 1. There was a signiﬁcant eﬀect of
group for categories achieved (F2,276=8.89, p=0.004)
and for perseverative errors (F2,276=4.17, p=0.008).
The eﬀects of BPRS score and IQ were not signiﬁcant
(p>0.25) for either analysis. Patients with SZ achieved
fewer categories and made more perseverative errors
than the other groups. We repeated the analysis with
smoking status (smoking versus non-smoking) as an
additional factor ; the results remained unchanged and
no signiﬁcant main eﬀect of smoking status was de-
tected (F2,276=0.86, p=0.42).
IGT
Details of participants’ performance in the IGT are
shown in Table 1 and Fig. 1. We found a signiﬁcant
eﬀect of group (F2,276=3.93, p=0.02) and group-
by-block interaction (F2,276=8.06, p<0.0001) on net
score. Both patient groups underperformed compared
to healthy individuals, with SZ patients performing
worse than the other groups. There was a signiﬁcant
eﬀect of group on attention to gain or losses
(F2,276=10.89, p=0.001), expectancy learning (F2,276=
6.11, p=0.01) and response consistency (F2,276=12.16,
p<0.0001). There were no main or interactive eﬀects of
BRPS score, sex or IQ in any of the analyses (p>0.1).
Patients with BD scored higher on the attention to
gains or losses parameter compared to all other groups
(p<0.04) but were comparable to controls in terms
of expectancy learning and response consistency. By
contrast, patients with SZ were comparable to controls
in terms of attention to gains or losses but under-
performed in terms of expectancy learning and
Table 1. Demographic, clinical and cognitive characteristics of the sample
Healthy controls
(n=140)
Patients with SZ
(n=70)
Patients with BD
(n=70)
Demographic information
Age (years), mean (S.D.) 43.9 (11.2) 44.2 (10.9) 44.6 (11.3)
Gender (M:F) 71 :69 41 :39 37 :33
Clinical characteristics
Age of onset (years), mean (S.D.) – 25.2 (10.1) 26.1 (10.5)
Duration of illness (years), mean (S.D.) – 18.8 (10.9) 17.6 (10.8)
BPRS (total score), mean (S.D.) 24.4 (0.6) 29.1 (0.3) 27.4 (0.8)
History of psychosis, n (%) – 70 (100) 54 (77)
Medication, n (%)
FGAs – 8 (11) 3 (4)
SGAs – 64 (91) 39 (56)
Mood stabilizersa – 3 (4) 59 (84)
Antidepressants – 8 (11) 5 (7)
Cognitive task performance, mean (S.D.)
WAIS-R IQ 101.5 (4.6) 99.1 (5.9) 103.95 (6.1)
WCST categories achieved 5.6 (0.85) 4.3 (1.1) 5.2 (1.0)
WCST perseverative errors 1.2 (1.5) 5.7 (5.2) 3.2 (2.4)
IGT global net score 21.1 (30.1) 6.6 (26.7) 15.2 (30.5)
IGT attention to gains or losses 0.40 (0.3) 0.42 (0.3) 0.56 (0.2)
IGT expectancy learning 0.18 (0.2) 0.39 (0.4) 0.16 (0.1)
IGT response consistency 1.1 (1.4) x0.18 (2.9) 0.95 (2.7)
SZ, Schizophrenia ; BD, bipolar disorder ; M, male ; F, female ; S.D., standard deviation ; BPRS, Brief Psychiatric Rating Scale ;
FGA, ﬁrst-generation antipsychotic ; SGA, second-generation antipsychotic ; WAIS-R, Wechsler Adult Intelligence Scale –
Revised ; WCST, Wisconsin Card Sorting Test ; IGT, Iowa Gambling Task.
aMood stabilizers include lithium and anticonvulsants.
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response consistency compared to both other groups
(p<0.001). We repeated the analysis adding smoking
status (smoking versus non-smoking) as a factor ; the
results remained unchanged and no signiﬁcant main
eﬀect of smoking status was detected (F2,276=0.30,
p=0.58). Within the BD group we also investigated the
eﬀect of psychosis on the E–V parameters. First, a
multivariate analysis of variance (MANOVA) with the
E–V parameters as dependent variables and history of
psychosis as an independent factor did not reveal a
signiﬁcant eﬀect of psychosis (F1,68=0.16, p=0.69).
Second, the eﬀect size of the diﬀerence between
patients with BD with and without a history of psy-
chosis was small for all parameters (df0.26).
Correlations between clinical and cognitive data
For the entire sample, the global IGT net score corre-
lated positively with categories achieved in the WCST
(r=0.35, p<0.0001) and inversely with the number
of perseverative errors (r=x0.24, p=0.003).
Furthermore, categories achieved in the WCST were
negatively correlated with expectancy learning
(r=x0.18, p=0.003). This pattern was also seen when
correlations were examined within each diagnostic
category separately, with absolute r values of ranging
from 0.24 to 0.28 and p<0.03. No other correlations
between performance measures or with clinical
measures were signiﬁcant (p>0.22). This also applied
to correlations between the dose of current
antipsychotics and the WCST and IGT outcome vari-
ables (absolute r<0.08, p>0.24).
Discussion
Our results indicate that, during the IGT, SZ and BD
are associated with diagnosis-speciﬁc abnormalities in
the motivational, cognitive and response selection
components of the task. Patients with BD showed in-
creased attention to gains or losses compared to both
other groups. Patients with SZ had poor expectancy
learning and response consistency compared to
patients with BD and healthy individuals. These re-
sults were not attributable to non-speciﬁc eﬀects of
sex, IQ, psychopathology or medication.
Increased incentive salience of gains in BD
Our study conﬁrms previous reports of abnormal
incentive decision making in remitted BD patients
(Christodoulou et al. 2006 ; Adida et al. 2011). Adida
et al. (2011) reported that BD patients do not show
aberrant responses to penalties during the IGT. Our
results extend these ﬁndings to demonstrate that
patients with BD are more motivated by gains. Our
study is also comparable to that of Yechiam et al.
(2008), who also applied the E–V model when com-
paring IGT performance between remitted BD patients
(n=14) and healthy controls (n=14). Although their
reported mean of the attention to gains or losses
parameter (0.59) was identical to ours, the study was
negative because it was underpowered. However, it is
important to note that BD patients performed simi-
larly to controls in terms of expectancy learning and
response consistency, indicating that their ability to
extract and apply expectancies representing the an-
ticipated consequences of choosing a card from each
deck was not impaired. We therefore infer that BD
patients seem to ‘override’ these cognitive biases
because of the higher ‘ incentive salience’ placed on
gains (Berridge & Kringelbach, 2008). Our results are
also in agreement with Chandler et al. (2009), who
found that BD patients displayed a normal under-
standing of the context in which they were asked to
make choices relating to gains or losses ; this contex-
tual information, however, had diminished impact on
their behaviour. It is worth noting that their BD
sample consisted of high-functioning (mean IQ=122),
unmedicated, euthymic university students with
minimal duration of illness. This implies that the
decision-making strategies identiﬁed in this study are
also relevant to the earlier stages of the illness and are
independent of general intellectual ability. We suggest
that the concept of increased incentive salience of
gains provides an apt description of the behaviour of
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Fig. 1. (a) Performance in the Iowa Gambling Task. Net score
per 20-card block ; values represent group means for each
block. (b) Eﬀect size of case–control diﬀerence in
Expectancy–Valence parameters for each patient group.
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BD patients during the IGT as it reﬂects motivational
attitudes that are largely separable from contextual
information and planning (Berridge & Kringelbach,
2008). Although our ﬁndings capture trait strategies in
incentive decision making in BD, mood state at the
time of testing seems to have a signiﬁcant impact
on these strategies. The presence of depression may
increase the salience of negative outcomes (Roiser et al.
2009 ; Adida et al. 2011) whereas mania has been as-
sociated with increasingly erratic and random choices
(Minassian et al. 2004 ; Adida et al. 2008 ; Yechiam et al.
2008).
Decreased expectancy learning in SZ
SZ patients had reduced overall performance in the
IGT compared to controls, which adds to the existing
literature on abnormal incentive decision making in
this disorder (Beninger et al. 2003 ; Ritter et al. 2004 ;
Shurman et al. 2005 ; Sevy et al. 2007 ; Bellani et al. 2009 ;
Premkumar et al. 2008 ; Lee et al. 2009). Conﬁrming our
previous report (Premkumar et al. 2008), we found that
patients with SZ, in this independent sample, had re-
duced expectancy learning. This cognitive parameter
of the E–V model reﬂects the inﬂuence of associative
learning on behaviour ; larger values, such as were
seen in SZ patients, suggest that choices are guided by
the more recent outcomes whereas past outcomes are
discounted. Expectancy learning relies on monitoring
the distribution of gains and losses for each deck on
a trial-by-trial basis and on using this information to
extract general rules (expectancies) to predict the
likely outcome of card choices. As Bechara et al. (1998)
have shown, the ability to form and maintain online
representations of various options during incentive
decision making is dependent on executive function
mechanisms. The negative correlation observed be-
tween expectancy learning and categories achieved
in the WCST lends further support to this notion.
Our results therefore suggest that incentive decision-
making deﬁcits in SZ are linked to impairment in
executive functions associated with rule discovery.
This may also explain the lack of consistency in their
choices. In contrast to BD patients, patients with SZ
were comparable to controls on the attention to gains
or losses parameter. We infer that SZ patients experi-
enced similar reactions to gains and losses as controls
and that underperformance in the IGT in SZ is not at-
tributable to motivational processes. Taken together,
these ﬁndings can be best understood within the
framework proposed by Gold et al. (2008). According
to this model, patients with SZ have deﬁcits in incen-
tive decision making, despite normal motivational in-
ﬂuences, because of their reduced ability to process
‘representational complexity ’, which refers to the
process of simultaneous representation of the multiple
motivational and cognitive aspects of decision mak-
ing. The model further proposes that this deﬁcit
represents another facet of executive dysfunction
associated with SZ.
Implications for the relationship between BD and SZ
Decomposing the performance of patients with SZ or
BD during the IGT using motivational, cognitive and
response choice parameters derived from the E–V
model yielded signiﬁcant diagnostic diﬀerences.
Associative learning underlying the representation of
expectancies was disrupted in SZ, which reinforces
reports of abnormalities in reward-based learning in
this disorder (Gold et al. 2008), and implicates circuits
linking the associative striatum with the dorsal pre-
frontal cortex (Corlett et al. 2007). By contrast, BD was
associated with increased incentive salience of gains.
This is the ﬁrst study to demonstrate this in remitted
BD patients. Bermpohl et al. (2010) have shown that
similarly altered attention to rewards in manic BD
patients was associated with enhanced activity within
the ventral prefrontal cortex, a ﬁnding replicated dur-
ing incentive decision making in remitted BD patients
(Frangou et al. 2008 ; Jogia et al. 2011). Our results
therefore point to dissociable abnormalities in incen-
tive decision making in BD and SZ that could poten-
tially be mapped to diﬀerent neural circuits.
Methodological considerations
All patients were medicated at the time of testing with
a variety of psychotropics. Antipsychotic medication,
particularly with FGAs, is known to aﬀect moti-
vational and reward-based processes (Beninger et al.
2003 ; Juckel et al. 2006; Sevy et al. 2006 ; Schlagenhauf
et al. 2008). At the same time, consistent with other
colleagues (e.g. Cavallaro et al. 2003 ; Premkumar et al.
2008), we did not ﬁnd signiﬁcant correlations between
IGT performance and antipsychotic dose. It was not
possible to conduct subanalyses based on medication
type alone as the size of the corresponding groups was
small and therefore comparisons would not have been
meaningful. There was a signiﬁcant diﬀerence in the
proportion of regular cigarette smokers between the
diagnostic groups. However, the inclusion of smoking
status as an independent factor did not alter our
ﬁndings and the eﬀect of smoking status was not
statistically signiﬁcant.
To summarize, we have presented data showing
that trait incentive decision-making abnormalities in
SZ and BD can be attributed to dissociable processes
respectively relating to expectancy learning and at-
tention to gains or losses. Further studies are required
Dissociable processes in incentive decision making in BD and SZ 7
to examine the relevance of these behavioural
observations to the biological correlates of these two
disorders.
Supplementary material
For supplementary material accompanying this paper
visit http://dx.doi.org/10.1017/S0033291712001304.
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